PSNC highlights pharmacy to Darzi review

Lord Darzi |
Three areas in which the development of community pharmacy services will help achieve the Government’s aim of shifting health care from secondary to primary care services have been highlighted by the Pharmaceutical Services Negotiating Committee.
Responding to the
second phase of Lord Darzi’s review of the NHS
in England (PJ, 20 October, p427), the PSNC said that national commissioning
of a pharmacy-based minor ailment scheme would overcome a shortfall of
GP capacity. The PSNC pointed out that 52 million GP consultations every
year are for minor ailments alone.
“The existing [minor ailment] schemes, commissioned locally, have
demonstrated their value in a number of patient satisfaction and academic
evaluations,
but access to the schemes is not uniformly available to all patients,” the
PSNC said.
It called for a national scheme to be supported by national promotion
in order to engineer a change in consumer behaviour so that they make
greater use of the pharmacy service.
Lord Darzi was also told by the PSNC that the management of long-term
conditions in pharmacies could be expanded, as could encouraging healthy
lifestyles. Possible services included managing anticoagulant patients
so that they would not need to travel to hospital clinics for blood tests
and dose adjustment and current pathfinder pharmacy services for managing
weight and obesity.
Sue Sharpe, PSNC chief executive, said: “Community pharmacy has
a substantial part to play in future care provision in the NHS. Our response
highlights the areas where community pharmacy can play a greater role
in contributing to improving care, especially through minor ailments
services, managing long-term conditions and provision of both advice
and services that allow patients to make an informed choice about healthy
lifestyles.
“There is a great contribution that community pharmacy can make
to helping the NHS build capacity to manage future demands. We hope Lord
Darzi and
his advisers recognise this.”
|